SEC14L4

SEC14L4 (TAP3) is a SEC14p-like protein that combines lipid/tocopherol binding with a role in stabilizing an RNA helicase to drive tumor cell growth (PMID:15567179, PMID:41741625). As a recombinant protein it binds alpha-, beta-, gamma-, and delta-tocopherol, select phospholipids, and squalene, and exhibits intrinsic GTPase activity comparable to Rab-family small GTP-binding proteins, with GTPase-related motifs spatially positioned to form a functional GTP-binding and hydrolysis site (PMID:15567179). In esophageal squamous cell carcinoma, SEC14L4 directly interacts with DDX3X and blocks RNF39-mediated ubiquitination and proteasomal degradation of DDX3X, thereby stabilizing it; this places SEC14L4 upstream of DDX3X in a pathway that activates MAPK signaling and suppresses ferroptosis, and loss of SEC14L4 reduces proliferation, migration, and colony formation while promoting apoptosis in a manner rescued by DDX3X overexpression (PMID:41741625). Beyond these biochemical and oncogenic activities, the mechanistic integration of SEC14L4's lipid-binding and GTPase functions with its DDX3X-stabilizing role has not been characterized in the available corpus.

1. 2005 Medium

   Established the biochemical identity of SEC14L4 as a SEC14p-like ligand-binding protein that also carries intrinsic GTPase activity, defining two candidate molecular activities for an otherwise uncharacterized protein.

   Evidence Recombinant protein expressed in E. coli, purified, and assayed for tocopherol/phospholipid/squalene binding and GTP hydrolysis in vitro

   PMID:15567179

   Open questions at the time

   • No mutagenesis confirming the proposed GTPase active site
   • In vitro binding does not establish a physiological lipid ligand or cellular GTPase function
   • No cellular localization or pathway context
2. 2009 Low

   Documented gene-level complexity of human TAP3/SEC14L4, showing alternative splicing and a coding-region polymorphism, but did not link any variant to function.

   Evidence cDNA isolation, sequencing, and characterization of splice variants and polymorphism

   PMID:20012369

   Open questions at the time

   • No functional assay connecting splice variant or polymorphism to protein activity
   • Single molecular characterization method
   • No phenotypic consequence established
3. 2026 Medium

   Defined a cellular and oncogenic mechanism in which SEC14L4 stabilizes DDX3X by protecting it from RNF39-mediated degradation, linking SEC14L4 to MAPK activation and ferroptosis suppression in cancer.

   Evidence Reciprocal Co-IP with mass spectrometry, ubiquitination assays, MAPK/ferroptosis marker Western blots, knockdown/overexpression proliferation-migration-apoptosis assays, and xenograft models in ESCC cells

   PMID:41741625

   Open questions at the time

   • No independent replication beyond a single lab
   • How the 2005 lipid-binding/GTPase activities relate to DDX3X stabilization is unresolved
   • Direct interface mapping of the SEC14L4–DDX3X interaction not performed

• Whether SEC14L4's lipid/tocopherol binding and GTPase activity mechanistically contribute to its DDX3X-stabilizing, pro-tumorigenic role, and whether this function extends beyond esophageal squamous cell carcinoma, remain open.
• No structural model of the SEC14L4–DDX3X complex
• No demonstration that GTPase activity is required for DDX3X stabilization
• Physiological (non-cancer) role uncharacterized